Positive benefit of postnatal treatment in congenital toxoplasmosis

Arch Dis Child. 2007 Jan;92(1):88-9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiprotozoal Agents / therapeutic use*
  • Colombia / epidemiology
  • Humans
  • Infant, Newborn
  • Mass Screening
  • Toxoplasmosis, Congenital / drug therapy*
  • Toxoplasmosis, Congenital / mortality

Substances

  • Antiprotozoal Agents